Advertisement
Roche
Roche

Neurologist Reveals Insider Information

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

By | November 26, 2012

Flickr, jollyUKSidney Gilman, former chair of the neurology department at the University of Michigan Medical School, has been sued by federal authorities for providing a hedge fund information about clinical trials for an Alzheimer’s drug under development by Elan and Wyeth that led to the fund dumping stocks and making more than $270 million.

The man at the head of the investigation is Mathew Martoma, a portfolio manager at hedge fund firm SAC Capital Advisors, although prosecutors are also looking into wrongdoing by the company’s owner Steven Cohen. Martoma is charged with making trades based on information from Gilman. 

 Preet Bharara, the United States attorney who brought the case to court, called the transaction “the most lucrative insider trading scheme ever charged,” in an interview with The New York Times.

Gilman, who is 80, served as a consultant to Martoma, receiving nearly $108,000 for his expertise.  He also helped oversee the Alzheimer’s trial and is accused of providing information regarding, at first, the drug’s positive results, and later, it’s failure, allowing Martoma to invest and pull out at the right times. Lawyers have promised not prosecute Gilman in exchange for his cooperation. However, Gilman may still face disciplinary action by the University of Michigan, who is reviewing the neuroscientist’s actions as a consultant and waiting to hear what additional information is uncovered during the trial.

(Hat tip to ScienceInsider)

Correction (November 26, 2012): Sidney Gilman is a former chair of the neurology department at the University of Michigan Medical School, rather than a current chair, as was written.  The Scientist regrets the error.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: BobD

BobD

Posts: 20

November 26, 2012

Dr. Gillman may have just bumped Martha Stewart off the "Clueless Insider Trading Hall of Fame."

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies